About North China Pharmaceutical
North China Pharmaceutical, known by its initials NCPC, is one of China's historic pharmaceutical manufacturers and is headquartered in Shijiazhuang, the capital of Hebei Province. The group was founded in 1953 and started commercial antibiotic production in 1958, a milestone that made it a pioneer of China's modern antibiotics industry. Its listed arm, North China Pharmaceutical Company, trades on the Shanghai Stock Exchange and carries the group's industrial and commercial activity.
The company develops, manufactures and sells antibiotics and semi-synthetic antibacterial agents, pharmaceutical intermediates, synthetic vitamins such as vitamin B12, biotechnology products, veterinary medicines and nutraceuticals, in both bulk and finished dosage forms. Its historical catalogue covers more than 430 products, including penicillins, cephalosporins, streptomycin, oxytetracycline, lincomycin and active ingredients such as 6-APA and amoxicillin, alongside large-scale output of powders for injection and capsules.
NCPC serves pharmaceutical distributors, hospitals, pharmacy chains and clinics in China and international markets, relying on fermentation and synthesis capacity built over decades. The company combines active ingredient production with finished medicines and runs complementary lines in animal health and health products, ranking among the world's large-scale producers of bulk antibiotics and vitamins.
The company develops, manufactures and sells antibiotics and semi-synthetic antibacterial agents, pharmaceutical intermediates, synthetic vitamins such as vitamin B12, biotechnology products, veterinary medicines and nutraceuticals, in both bulk and finished dosage forms. Its historical catalogue covers more than 430 products, including penicillins, cephalosporins, streptomycin, oxytetracycline, lincomycin and active ingredients such as 6-APA and amoxicillin, alongside large-scale output of powders for injection and capsules.
NCPC serves pharmaceutical distributors, hospitals, pharmacy chains and clinics in China and international markets, relying on fermentation and synthesis capacity built over decades. The company combines active ingredient production with finished medicines and runs complementary lines in animal health and health products, ranking among the world's large-scale producers of bulk antibiotics and vitamins.